Re: Chia et al.: Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops (Ophthalmology 2016;123:391-9)

Ophthalmology. 2016 Jun;123(6):e40-1. doi: 10.1016/j.ophtha.2015.12.037.

Authors

Virgilio Galvis¹, Alejandro Tello¹, M Margarita Parra², Carlos J Rodriguez³, Oscar Blanco³

Affiliations

¹ Ophthalmologist Supraspecialist in Cornea, Refractive Surgery and Anterior Segment, Fundación Oftalmológica de Santander FOSCAL, Floridablanca, Colombia.
² Ophthalmology Resident, Fundación Oftalmológica de Santander FOSCAL, Universidad Industrial de Santander UIS, Bucaramanga, Colombia. Electronic address: mariamargaritaparrac@gmail.com.
³ Optometrist, Centro Oftalmológico Virgilio Galvis, Floridablanca, Colombia.

PMID: 27210609
DOI: 10.1016/j.ophtha.2015.12.037

No abstract available

Publication types

Letter
Comment

MeSH terms

Atropine*
Humans
Mydriatics
Myopia
Ophthalmic Solutions*

Substances

Mydriatics
Ophthalmic Solutions
Atropine

Supplementary concepts

Myopia 2